'Second' remote monitoring market larger than first? Juniper Research

Juniper Research updates its mHealth study from the spring [TA 22 April] on its blog with a few thoughts.  While cardiac monitoring accounts for most of the present activity, the ‘secondary’ diseases for monitoring, including diabetes, COPD and asthma, could eventually be a much larger market.  Interesting fact:  most companies in chronic disease management are venture-backed at $10 million or less.  Cost savings?  Yes, maybe, and these companies have to convince the payor market of it to break out of this ‘shell’.  AnalystXpress blog.